Efficacy and tolerability of Escitalopram in patients with moderate to severe depression with or without comorbid anxiety

被引：1
|
作者：
Stamouli, S. [1 ]
Vidalis, A. [2 ]
Stathakis, I. [3 ]
Bastas, H. [4 ]
Koulis, S. [5 ]
机构：
[1] Eginit Univ Hosp Athens, Psychiat Clin, Athens, Greece
[2] Ippokrateion Gen Hosp Thessaloniki, Psychiat Clin, Thessaloniki, Greece
[3] Papanikolaou Gen Hosp Thessaloniki, Psychiat Clin, Thessaloniki, Greece
[4] Ctr Mental Hlth, Iraklion, Greece
[5] Ctr Mental Hlth, Patras, Greece
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.342
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [31] Escitalopram treatment of social anxiety disorder with comorbid major depression
    Schneier, FR
    Blanco, C
    Campeas, R
    Lewis-Fernandez, R
    Sanchez-Lacay, A
    Liebowitz, MR
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S206 - S206
  • [32] A comparison of efficacy and tolerability of Vilazodone and Escitalopram in the management of depression
    Duraisamy, Karthik
    Selvan, C. Panneer
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S143 - S143
  • [33] CYP2C19 INFLUENCE ON ESCITALOPRAM EFFICACY AND TOLERABILITY IN YOUTH WITH ANXIETY AND DEPRESSION
    Ramsey, Laura B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S301 - S301
  • [34] Efficacy and tolerability of venlafaxine in patients hospitalized with moderate to severe depression: An open-label pilot study
    Borgherini, G
    Conforti, D
    Cognolato, S
    Scarso, C
    Bernardis, LAF
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (12): : 672 - 680
  • [35] Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache
    Yao Wang
    Xiaoyu Yang
    Xiaojun Ji
    Min Liu
    Chang Zhou
    [J]. Psychopharmacology, 2023, 240 : 2061 - 2070
  • [36] Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache
    Wang, Yao
    Yang, Xiaoyu
    Ji, Xiaojun
    Liu, Min
    Zhou, Chang
    [J]. PSYCHOPHARMACOLOGY, 2023, 240 (10) : 2061 - 2070
  • [37] EFFECTIVENESS AND TOLERABILITY OF ESCITALOPRAM IN THE TREATMENT OF DEPRESSION WITH OR WITHOUT MENTAL AND/OR SOMATIC COMORBIDITIES
    Yfantis, A.
    Giailoglou, D.
    Chourdaki, E.
    Sotiriadou, K.
    Laggis, N.
    Markoula, S.
    Sotiriou, M.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [38] Comorbid depression and anxiety in patients of epilepsy
    Gupta, Geetanjali
    Kesri, Raghav
    Goyal, Suchita
    Karia, Sagar
    [J]. ANNALS OF INDIAN PSYCHIATRY, 2022, 6 (02) : 137 - 141
  • [39] Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression
    Bun'kova, K. M.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (03): : 29 - 32
  • [40] Tolerability and safety of escitalopram in randomised controlled trials in major depression and anxiety disorders
    Baldwin, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S317 - S318
12345